507 related articles for article (PubMed ID: 25500240)
1. Current status of bioresorbable scaffolds in the treatment of coronary artery disease.
Wiebe J; Nef HM; Hamm CW
J Am Coll Cardiol; 2014 Dec; 64(23):2541-51. PubMed ID: 25500240
[TBL] [Abstract][Full Text] [Related]
2. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
[TBL] [Abstract][Full Text] [Related]
3. Bioresorbable scaffold - A magic bullet for the treatment of coronary artery disease?
Brie D; Penson P; Serban MC; Toth PP; Simonton C; Serruys PW; Banach M
Int J Cardiol; 2016 Jul; 215():47-59. PubMed ID: 27111160
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
[No Abstract] [Full Text] [Related]
5. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
6. Coronary Bioresorbable Vascular Scaffold Use in the Treatment of Coronary Artery Disease.
Testa L; Latib A; Montone RA; Colombo A; Bedogni F
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412870
[TBL] [Abstract][Full Text] [Related]
7. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
8. Bioresorbable scaffolds for the treatment of in-stent restenosis.
Dörr O; Liebetrau C; Wiebe J; Hecker F; Rixe J; Möllmann H; Hamm C; Nef H
Heart Vessels; 2015 Mar; 30(2):265-9. PubMed ID: 24390727
[TBL] [Abstract][Full Text] [Related]
9. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
[TBL] [Abstract][Full Text] [Related]
10. Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives.
Kitabata H; Waksman R; Warnack B
Cardiovasc Revasc Med; 2014 Mar; 15(2):109-16. PubMed ID: 24684760
[TBL] [Abstract][Full Text] [Related]
11. A review of bioresorbable scaffolds: hype or hope?
Tan HC; Ananthakrishna R
Singapore Med J; 2017 Sep; 58(9):512-515. PubMed ID: 27868135
[TBL] [Abstract][Full Text] [Related]
12. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
[TBL] [Abstract][Full Text] [Related]
13. Bioresorbable Stents: Is This Where We Are Headed?
Wayangankar SA; Ellis SG
Prog Cardiovasc Dis; 2015; 58(3):342-55. PubMed ID: 26319497
[TBL] [Abstract][Full Text] [Related]
14. [The bioresorbable coronary scaffold].
Hassell ME; van de Hoef TP; Damman P; Delewi R; Serruys PW; Piek JJ
Ned Tijdschr Geneeskd; 2012; 156(36):A4994. PubMed ID: 22951133
[TBL] [Abstract][Full Text] [Related]
15. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
16. Intravascular bioresorbable polymeric stents: a potential alternative to current drug eluting metal stents.
Sharkawi T; Cornhill F; Lafont A; Sabaria P; Vert M
J Pharm Sci; 2007 Nov; 96(11):2829-37. PubMed ID: 17979210
[TBL] [Abstract][Full Text] [Related]
17. Bioresorbable Scaffold: The Emerging Reality and Future Directions.
Sotomi Y; Onuma Y; Collet C; Tenekecioglu E; Virmani R; Kleiman NS; Serruys PW
Circ Res; 2017 Apr; 120(8):1341-1352. PubMed ID: 28408454
[TBL] [Abstract][Full Text] [Related]
18. Bioresorbable Scaffolds for Coronary Artery Disease.
Nathan A; Kobayashi T; Kolansky DM; Wilensky RL; Giri J
Curr Cardiol Rep; 2017 Jan; 19(1):5. PubMed ID: 28108898
[TBL] [Abstract][Full Text] [Related]
19. [Bioresorbable Vascular Scaffold: A Focused Review on Development and Preclinical Studies].
Ke L; Huang Y; Liu L; Duan X; Feng X; Wang C
Zhongguo Yi Liao Qi Xie Za Zhi; 2018 Feb; 42(2):115-118. PubMed ID: 29845812
[TBL] [Abstract][Full Text] [Related]
20. Bioresorbable scaffolds for the treatment of coronary artery disease: current status and future perspective.
Kraak RP; Grundeken MJ; Koch KT; de Winter RJ; Wykrzykowska JJ
Expert Rev Med Devices; 2014 Sep; 11(5):467-80. PubMed ID: 25087771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
